A prospective randomised controlled study of the use of ranitidine in patients with gastric cancer

Gut

Volumn 42, Issue 1, 1998, Pages

  Primrose, J N ^a,c   Miller, G V ^a   Preston, S R ^a   Gokhale, J ^a   Ambrose, N S ^a   Ward, U M ^a   Mills, J G ^b   Ehsanullah, R S B ^b   Darekar, B ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cimetidine; Gastric cancer; H2 histamine receptor antagonist; Rantitidine

Indexed keywords

RANITIDINE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GASTRECTOMY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER; TREATMENT OUTCOME;

EID: 7144223399     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.1.17     Document Type: Article

References (11)

1. Cancer Research Council. Factsheet 18. London: Cancer Research Campaign, 1993.
2. Fielding JWL, Roginski C, Ellis DJ, et al. Clinicopathological staging of gastric cancer. Br J Surg 1984;71:667-80.
3. Tonnesen H, Bulow S, Fischerman K, et al. The effect of cimetidine on survival after gastric cancer. Lancet 1988;ii: 990-2.
4. Svendsen LB, Ross C, Knigge U, et al. Cimetidine as an adjuvant treatment in colorectal cancer. A double-blind, randomized pilot study. Dis Colon Rectum 1995;38:514-18.
5. Gifford RRM, Tilberg AF. Histamine type 2 receptor antagonist immune modulation. II. Cimetidine and ranitidine increase interleukin 2 production. Surgery 1987;102: 242-7.
6. Griswold DE, Alessi S, Badger AM, et al. Inhibition of T suppressor cell expression by histamine type 2 receptor antagonists. J Immunol 1984;132:3054-7.
7. Hahm KB, Lee SI, Chung JP, et al. Comparison of immunomodulative effects of histamine-2 receptor antagonists in gastric cancer patients: focus on the lymphoblastogenesis and cytotoxicity of peripheral blood mononuclear cells. Int J Immunopharmacol 1994;16:985-93.
8. 2 receptors. Cancer Res 1982;42:1542.
9. Watson SA, Wilkinson LJ, Robertson JF, Hardcastle JD. Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine. Gut 1993;34:1091-6.
10. Colin-Jones DG, Langman MJ, Lawson DH, et al. Postmarketing surveillance of the safety of cimetidine: 10 year mortality report. Gut 1992;33:1280-4.
11. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992;339:1-15, 71-85.